BELLUS Health Inc. (BLU) Fundamentals

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
SHARE INFORMATION
Market Cap$ 1,008,859,186
Shares Outstanding126,561,610
Float125,792,916
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 15,111
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions217
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months17,762,801
Institutional Holdings Percent96.7%
Institutional Sold Previous 3 Months9,599,566
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 12.69
52 Week Low$ 5.45
52 Week High Change$ 33.67
21 Day Moving Average$ 8.0364
21 Day Extended Moving Average$ 8.1167
50 Day Moving Average$ 8.8365
50 Day Extended Moving Average$ 8.6331
200 Day Moving Average$ 9.3126
200 Day Extended Moving Average$ 8.8198
10 Day Average Volume573,154
20 Day Average Volume669,124
30 Day Average Volume589,504
50 Day Average Volume587,746
Alpha0.037952
Beta-0.2739
Standard Deviation0.212746
R20.005748
7 Day Price Change$ 0.46
7 Day Percent Change6.08%
21 Day Price Change$ -0.51
21 Day Percent Change-5.98%
30 Day Price Change$ -0.87
30 Day Percent Change-9.79%
Month to Date Price Change$ -0.20
Month to Date Percent Change-2.43%
Quarter to Date Price Change$ -0.20
Quarter to Date Percent Change-2.43%
180 Day Price Change$ -1.09
180 Day Percent Change-11.96%
200 Day Price Change$ -2.79
200 Day Percent Change-25.81%
Year to Date Price Change$ -0.20
Year to Date Percent Change-2.43%

BELLUS Health Inc. (BLU) Key Ratios

PROFITABILITY
EBIT Margin-454,312.5%
EBITDA Margin-452,606.3%
Pre-Tax Profit Margin-141,833.5%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 12,404
Revenue Per Share$ 0.0001
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.70
Total Debt To Equity0.00
Int Coverage-1,101.40
Current Ratio17.00
Leverage Ratio1.10
Quick Ratio16.40
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-11.90
Enterprise Value$ 590,383,060
Price to Sales81,830.39
Price to Free Cash-21.00
PE High Last 5 Years-13.70
Price To Book2.50
Price To Cash Flow0.00
PE Low Last 5 Years-13.00
Price to Tangible Book2.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-27.59
Return on Equity-29.78
Return on Capital-29.87

BELLUS Health Inc. (BLU) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEORoberto Bellini
Emplyoees40
Last AuditUQ
CIK0001259942
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address275 Armand-Frappier Boulevard
Laval, QC H7V 4A7
Websitehttp://www.bellushealth.com
Facsimile+1 450 680-4501
Telephone+1 450 680-4500
Emailir@bellushealth.com


Your Recent History
NASDAQ
BLU
BELLUS Hea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.